Patent Assignment
Reel/Frame 021893/0336
Assignment of Assignor's Interest
Recorded: 2008-11-26
Pages: 114
Assignor
BAYER PHARMACEUTICALS CORPORATION
Executed: 2007-11-13
Assignee
BAYER HEALTHCARE LLC
555 WHITE PLAINS ROAD, TARRYTOWN, NEW YORK, 10591
Covered Properties
(10)
Inhibition of P38 Kinase Activity Using Substituted Heterocyclic Ureas
Application:
09/458,014 →
Inhibition of Raf Kinase Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
Patent:
7,329,670 →
Application:
09/472,232 →
Inhibition of Raf Kinase Using Substituted Heterocyclic Ureas
Application:
09/640,780 →
INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
Application:
09/776,935 →
Inhibition of Raf Kinase Using Symmetrical and Unsymmetrical Substituted Diphenyl Ureas
Application:
09/776,936 →
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
Application:
09/778,039 →
Inhibition of P38 Kinase Using Symmetrical and Unsymmetrical Diphenyl Ureas
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
Application:
10/086,417 →
Publication:
US 2003/0105091
Inhibition of Raf Kinase Using Substituted Heterocyclic Ureas
Application:
11/768,112 →
Publication:
US 2007/0244120
Inhibition of Raf Kinase Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.